Kim Etchevers

Mucosal p-STAT1/3 correlates with histologic disease activity in Crohn’s disease and is responsive to filgotinib

S. Vermeire, W. Reinisch, X. Hébuterne, 2022, Tissue barriers.

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

A. Mathias, Saili Yi, C. Nelson, 2020, Clinical Pharmacokinetics.